# Abram Scientific

> Abram Scientific is a Menlo Park, California medical-device company building CoagCare, a portable point-of-care platform that reads the full blood-coagulation cascade - from clot formation through fibrinolysis - from a single drop of blood in under 10 minutes. By measuring blood viscoelasticity and density on single-use test cards inside a vibration-insensitive handheld meter, CoagCare aims to move coagulation testing out of the central lab and into trauma bays, ambulances, and MEDEVAC helicopters, helping clinicians decide the right transfusion or therapy at the right time.

- **Headquarters:** Menlo Park, California, United States
- **Founders:** Abhishek Ramkumar (Founder & CEO, inventor of the CoagCare platform)
- **Team size:** ~7 employees
- **Products:** CoagCare System, DOAC / anticoagulant monitoring
- **Notable:** Closed an $11.75M Series A in February 2026 led by Octapharma AG., Raised roughly $15.1M in total funding to date., Secured ~$3.4M in non-dilutive federal funding from NSF and the Department of Defense, with a 100% Phase I-to-Phase II SBIR conversion rate.

## Products & services

- **CoagCare System** — A portable, handheld point-of-care meter paired with single-use test cards that measures blood viscoelasticity and density to characterize the entire coagulation cascade - from clot formation through fibrinolysis - in under 10 minutes from a single drop of blood. Its vibration-insensitive design allows use in ambulances, MEDEVAC helicopters, and other non-laboratory environments.
- **DOAC / anticoagulant monitoring** — Application of the CoagCare platform to differentiate between Direct-Acting Oral Anticoagulants and help identify appropriate reversal agents, supporting emergency and surgical decision-making.

## Achievements

- Closed an $11.75M Series A in February 2026 led by Octapharma AG.
- Raised roughly $15.1M in total funding to date.
- Secured ~$3.4M in non-dilutive federal funding from NSF and the Department of Defense, with a 100% Phase I-to-Phase II SBIR conversion rate.
- Won a $2.9M U.S. Army medical research grant for COVID-19-associated coagulopathy management.
- Built a portfolio of 17 granted U.S. and international patents, with more pending.
- Engineered a vibration-insensitive viscoelastic measurement suitable for moving vehicles and aircraft.

## Latest updates

- **2026-02** — Closed $11.75M Series A financing led by Octapharma AG to advance CoagCare toward clinical milestones and FDA 510(k) clearance.
- **2021-01** — Secured a $2.9M U.S. Army medical research grant to deliver a portable viscoelastic blood-coagulation platform for COVID-19-associated coagulopathy.

## Links

- Website: https://abramscientific.com
- LinkedIn: https://www.linkedin.com/company/abram-scientific
- Twitter/X: https://twitter.com/AbramScientific

---

Profile page: https://yespress.io/abram-scientific
Published by YesPress — https://yespress.io
Last updated: 2026-06-16